Enfuvirtide: A Review of its Use in the Management of HIV Infection

@article{Oldfield2005EnfuvirtideAR,
  title={Enfuvirtide: A Review of its Use in the Management of HIV Infection},
  author={Vicki Oldfield and Gillian M. Keating and Greg L. Plosker},
  journal={Drugs},
  year={2005},
  volume={65},
  pages={1139-1160}
}
Enfuvirtide (Fuzeon®), a fusion inhibitor, is indicated in combination with other antiretroviral agents in the treatment of HIV infection in treatment-experienced adults and children aged >6 years. The addition of subcutaneous enfuvirtide to an optimised antiretroviral background regimen improved the virological and immunological response in treatment-experienced HIV-infected patients in the two large, well designed TORO (T-20 vs Optimised Regimen Only) trials. Although injection-site reactions… CONTINUE READING